SANARIA INC.

Company Information
Address 9800 MEDICAL CENTER DR STE A209
ROCKVILLE, MD, 20850-6395

http://www.sanaria.com

Information

DUNS: 131092715

# of Employees: 47


Ownership Information

Hubzone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Automating mosquito microdissection for a malaria PfSPZ vaccine

    Amount: $997,637.00

    ABSTRACT The global death toll from Malaria is estimated to be upwards of people each year with more than children succumbing every day Plasmodium falciparum Pf Sporozoite SPZ bas ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  2. Marketing Strategic Plan and Distribution Logistics for Sanaria PfSPZ Vaccine against Malaria.

    Amount: $996,292.00

    ABSTRACT The development of Sanaria s Plasmodium falciparum Pf sporozoite SPZ based vaccines is receiving overwhelming global support after the publication in in Science of clinical data show ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  3. Universal Attenuated Sporozoite Vaccine and Challenge System

    Amount: $1,959,724.00

    ABSTRACT Sanaria s Plasmodium falciparum Pf sporozoite SPZ vaccines development program is receiving global support Trials of PfSPZ Vaccine radiation attenuated PfSPZ or PfSPZ CVac PfSPZ Chemo ...

    SBIRPhase II2016Department of Health and Human Services National Institutes of Health
  4. Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites (PvSPZ Challenge) for controlled human malaria infection (CHMI)

    Amount: $600,000.00

    DESCRIPTION provided by applicant Plasmodium vivax Pv the second most important human malaria parasite causes more than million cases annually including severe fatal disease Prevention and ...

    SBIRPhase I2016Department of Health and Human Services National Institutes of Health
  5. A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with a live attenuated sporozoite malaria vaccine

    Amount: $2,000,000.00

    DESCRIPTION provided by applicant The world needs a highly effective malaria vaccine Sanaria r PfSPZ Vaccine composed of aseptic purified cryopreserved radiation attenuated PfSPZ protected ...

    SBIRPhase II2016Department of Health and Human Services National Institutes of Health
  6. PfSPZ Vaccines: Quality Systems, Manufacturing, Regulatory, and Clinical Quality and Data Management Support for Product Commercialization

    Amount: $991,532.00

    ABSTRACT Sanaria s Plasmodium falciparum Pf sporozoite SPZ vaccines development program is receiving overwhelming global support Eleven trials of Sanaria s two primary PfSPZ vaccines which includ ...

    SBIRPhase II2016Department of Health and Human Services
  7. Development of a whole parasite Plasmodium falciparum sexual and mosquito stages Vaccine to Interrupt Malaria Transmission

    Amount: $613,413.00

    DESCRIPTION provided by applicant This proposal will demonstrate proof of concept for a whole parasite WP vaccine directed against Plasmodium falciparum Pf sexual and mosquito stages SMS tha ...

    SBIRPhase I2015Department of Health and Human Services
  8. In-Vitro Culture of Plasmodium falciparum Sporozoites for Malaria Vaccine

    Amount: $2,999,990.00

    DESCRIPTION provided by applicant Sanariaandapos s platform technology is production of aseptic purified cryopreserved Plasmodium falciparum Pf sporozoites SPZ This technology has produced t ...

    SBIRPhase II2015Department of Health and Human Services National Institutes of Health
  9. Genetically Attenuated PfSPZ Malaria Vaccine

    Amount: $2,999,987.00

    DESCRIPTION provided by applicant We build on the successful work in Phase II SBIR R AI in which a genetically attenuated Plasmodium falciparum Pf parasite GAP was produced and shown ...

    SBIRPhase II2015Department of Health and Human Services National Institutes of Health
  10. Automating mosquito microdissection for a malaria PfSPZ vaccine

    Amount: $599,998.00

    DESCRIPTION Malaria causes andgt million clinical cases and million deaths annually is responsible for andgt loss of GDP in Africa and is a serious concern for travelers and military perso ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health

Agency Micro-sites

US Flag An Official Website of the United States Government